Literature DB >> 12204664

Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity.

G Cavaletti1, C Zanna.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12204664     DOI: 10.1016/s0959-8049(02)00229-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


× No keyword cloud information.
  22 in total

Review 1.  Insulin-like growth factors in the peripheral nervous system.

Authors:  Kelli A Sullivan; Bhumsoo Kim; Eva L Feldman
Journal:  Endocrinology       Date:  2008-08-21       Impact factor: 4.736

Review 2.  Value of Supportive Care Pharmacogenomics in Oncology Practice.

Authors:  Jai N Patel; Lauren A Wiebe; Henry M Dunnenberger; Howard L McLeod
Journal:  Oncologist       Date:  2018-04-05

Review 3.  Current use of drugs affecting the central nervous system for chemotherapy-induced peripheral neuropathy in cancer patients: a systematic review.

Authors:  Sang Hui Chu; Young Joo Lee; Eon Sook Lee; Yimin Geng; Xin Shelley Wang; Charles S Cleeland
Journal:  Support Care Cancer       Date:  2014-09-26       Impact factor: 3.603

4.  Targeting Cannabinoid 1 and Delta Opioid Receptor Heteromers Alleviates Chemotherapy-Induced Neuropathic Pain.

Authors:  Salvador Sierra; Achla Gupta; Ivone Gomes; Mary Fowkes; Akila Ram; Erin N Bobeck; Lakshmi A Devi
Journal:  ACS Pharmacol Transl Sci       Date:  2019-06-05

5.  Chemotherapy-Induced Peripheral Neuropathy in Pediatric Cancer Patients.

Authors:  Rhonda J Moore; Hunter Groninger
Journal:  Cureus       Date:  2013-06-14

6.  Tapentadol in neuropathic pain cancer patients: a prospective open label study.

Authors:  Edvina Galiè; Veronica Villani; Irene Terrenato; Andrea Pace
Journal:  Neurol Sci       Date:  2017-07-11       Impact factor: 3.307

7.  Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).

Authors:  Ganesh K Boora; Amit A Kulkarni; Rahul Kanwar; Peter Beyerlein; Rui Qin; Michaela S Banck; Kathryn J Ruddy; Josef Pleticha; Cynthia A Lynch; Robert J Behrens; Stephan Züchner; Charles L Loprinzi; Andreas S Beutler
Journal:  J Neurol Sci       Date:  2015-06-27       Impact factor: 3.181

8.  Randomized sham-controlled pilot trial of weekly electro-acupuncture for the prevention of taxane-induced peripheral neuropathy in women with early stage breast cancer.

Authors:  Heather Greenlee; Katherine D Crew; Jillian Capodice; Danielle Awad; Donna Buono; Zaixing Shi; Anne Jeffres; Sharon Wyse; Wendy Whitman; Meghna S Trivedi; Kevin Kalinsky; Dawn L Hershman
Journal:  Breast Cancer Res Treat       Date:  2016-03-25       Impact factor: 4.872

Review 9.  Supportive care for patients with early breast cancer.

Authors:  Laura García-Estévez; Ignasi Tusquets; Isabel Alvarez; César Rodríguez; Yolanda Fernández; Miguel Angel Seguí; Jesús García-Mata; Ana Lluch
Journal:  Clin Transl Oncol       Date:  2010-01       Impact factor: 3.405

Review 10.  Natural products and complementary therapies for chemotherapy-induced peripheral neuropathy: A systematic review.

Authors:  Cloé Brami; Ting Bao; Gary Deng
Journal:  Crit Rev Oncol Hematol       Date:  2015-11-23       Impact factor: 6.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.